Browse by article | Browse by volume |
If you want to download the article, please login or register as reader.
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 5 - 17) Jovanovic M., Todorov N., Dickov A., Arsenijevic V., Kovacevic M., Mijailovic Z., and Colovic S. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 19 - 23) Subjective Opiate Withdrawal Scale and Toxicological Screening in Malaysian Opioid Drug Addicts Wiraagni I.A., Mohd M.A., Rashid R.b.A., and Haron D.E.b.M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 25 - 31) Ishrat S., Naz S., Gul I., and Sireer N. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 33 - 46) Opioid Agonist Treatment for Opioid Use Disorder Patients in Central Asia Michels I.I., Stöver H., Aizberg O., and Boltaev A. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 47 - 55) Phelan J.E. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 57 - 60) Riaz U. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 61 - 64) The ‘Prison Zero Hepatitits' Project in France: A New Pathway for Hcv Microelimination Remy A.-J., Roy B., and Hervet J. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 65 - 70) Switching All Patients from Racemic to Levomethadone as a Challenge to Public Health Deruvo G., Elia C., Mercadante M., Mongiello F., Guareschi M., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 71 - 79) Miccoli M., Della Rocca F., Maremmani A.G.I., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N1 (pages: 79 - 80) Crowley D., and Van Hout M.C. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 5 - 11) Weintraub E., Greenblatt A.D., Chang J., Welsh C.J., Berthiaume A.P., Goodwin S.R., Arnold R., Himelhoch S.S., Bennett M.E., and Belcher A.M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 13 - 27) Musa R., and Yee A. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 29 - 47) Agonist Opioid Treatment for Opioid Dependents in Germany 2019 Stöver H., Michels I.I., and Gerlach R. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 49 - 57) Ulmer A., Frietsch B., and Mueller M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 59 - 63) Obsessive Compulsive Disorder among Patients Enrolled in Methadone Maintenance Therapy Kheradmand A., Khalatabadi P., and Seif P. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 65 - 68) Rehabilitation of Patients Dependent on New Psychoactive Substances in Russian Federation Kekelidze Z.I., Kozlov A.A., Klimenko T.V., Igumnov S.A., and Shakhova S.M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 69 - 77) Miccoli M., Poli A., Pagni L., Conversano C., Pani P.P., Maremmani A.G.I., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N2 (pages: 79 - 80) Effectiveness of Deep Brain Stimulation in Treatment of Severe Addiction Famitafreshi H., and Karimian M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 5 - 11) Drugs as communication between ego and self. Revisiting C.G. Jung Leoncini T., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 13 - 21) Karabulut V., Evren C., Alniak İ., Helin Carkcı O., and Yilmaz Cengel H. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 23 - 27) Follow-up of serum naltrexone levels after naltrexone implant in opioid use disorder Kulaksızoğlu B., Erdoğan A., Cinemre B., Topcuoğlu M., Coşkun M.N., Özdemir M., Bingöl M.S., and Kuloğlu M.M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 29 - 36) Somatic diseases in patients with opioid use disorder Simonovska N., Velik-Stefanovska V., Babulovska A., Pereska Z., Kostadinoski K., and Naumoski K. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 37 - 44) Casado-Espada N.M., Alvarez-Navares A., Lozano-Lopez M.T., Gamonal-Limcaoco R.S., de la Iglesia-Larrad J., Garzón M.Á., Dening T., and Roncero C. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 45 - 50) Take-home naloxone carriage among opioid users in Lanarkshire Hill D.R., Al Azizi B., Conroy S., and Akram G. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 51 - 53) Tivari Bitri S., Puca E., Thoma E., and Sotiri E. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 55 - 60) Covid-19 and addiction: A comparison between Substance Use Disorder patients and gamblers Incerti C.C., Carenti M.L., Catalano G., De Luca O., Arcangeli N., Manasse D., and Casella P. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 61 - 74) Della Rocca F., Novi M., Maremmani A.G.I., Pani P.P., Miccoli M., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 77 - 81) Caring for opioid drug users during the COVID-19 pandemic – a commentary on the Irish experience Crowley D., and Cullen W. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N3 (pages: 81 - 85) Appel P. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 5 - 14) Lin M.-F., and Lang S.-Y. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 15 - 23) Effect of methadone and treadmill exercise on myocardial infarction in morphine withdrawn rats Alizadeh M., Miladi-Gorji H., Sameni H., Bandegi A., Ebadatipour E., and Zahedi-Khorasani M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 25 - 32) Yu K.-C., Wei H.-T., Chih S.-Z., and Hsu C.-H. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 33 - 41) Consoli A. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 43 - 50) Naltrexone Implant Use in Opioid Use Disorder; an example from Turkey Demir B., and Altindag A. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 51 - 58) An Assertive Outreach Intervention for Treatment of Opioid Use Disorder in Young Adults Wenzel K., Fishman M., Wildberger J., Vo H., and Burgower R. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 59 - 68) Methadone intoxications and methadone-related deaths during a five-year period in Vojvodina, Serbia Nosek I.P., Dušan, Mijatović Jovin V., Samojlik I., Petković S.D., Zorka Knezovic, Vladimir, and Dickov A. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N4 (pages: 69 - 79) Maremmani I., Hill D., Scherbaum N., Auriacombe M., Bacciardi S., Benyamina A., Casella P., D'Agnone O., Daulouede J.-P., Deruvo G., Fonseca F., Guareschi M., Maremmani A.G.I., Villeger P., Ratcliffe K., Somaini L., Touzeau D., Vernole E., Walcher S., and |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 5 - 14) Barlas L., Ünübol B., and Dağ İ. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 15 - 22) Gross G., Conroy S., Leonardi C., Meroueh F., Antolin J.M., and Somaini L. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 25 - 36) RBP-6000: a rationally designed prolonged-release buprenorphine formulation Wiest K., Shaya G., Somaini L., and Greenwald M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 37 - 45) Matthews E., Van Hout M.C., Scheibein F., and Cowman M. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 47 - 56) Sabeghi S., Zahedi-Khorasani M., Ghanbari A., Khaleghian A., Doroodi F., and Miladi-Gorji H. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 57 - 66) Microdosing Case Study Series – Transferring from Methadone to Oral Buprenorphine Cassells N., Hill D.R., Marr E., and Stewart E. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 67 - 73) What makes a co-dependent partner? - A linear regression model Knapek É., Balázs K., and Kuritárné Szabó I. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N5 (pages: 75 - 80) Maremmani A.G.I., Della Rocca F., Bacciardi S., Miccoli M., and Maremmani I. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 5 - 11) Involuntary Commitment for Opioid Use Disorders: Is There Any Predictor of Recommitments? Ak S., and Arikan R. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 13 - 24) Markovska-Simoska S., Ignjatova L., Kiteva-Trenchevska G., and Pop-Jordanova N. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 25 - 32) Jangipour Afshar P., Salehinejad S., and Shahesmaeili A. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 33 - 39) Sefranek M., McDonald R., Kelleher M., Breidahl S., Pavlidis P., Miovsky M., and Strang J. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 41 - 50) Different formulations of methadone and levomethadone in the management of Opioid Use Disorder. Somaini L., Vecchio S., Salvatore D.F., Ercolini A., and Leonardi C. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 51 - 57) Stella L., D'Ambra C., Di Donato L., Infantino R., Boccella S., Mirto B.F., Luongo L., Miele M., Pieretti G., Maione S., and Guida F. |
Heroin Addiction and Related Clinical Problems: 2021, 23, N6 (pages: 59 - 64) Maremmani A.G.I., Della Rocca F., Bacciardi S., Miccoli M., and Maremmani I. |
EUROPAD - European Opiate Addiction Treatment Association Brussels, Belgium, EU P. IVA 01681650469 – Codice Fiscale 94002580465 Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org |